Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand
To overcome pandemics, such as COVID-19, vaccines are urgently needed at very high volumes. Here we assess the techno-economic feasibility of producing RNA vaccines for the demand associated with a global vaccination campaign. Production process performance is assessed for three messenger RNA (mRNA)...
Egile Nagusiak: | Zoltán Kis, Cleo Kontoravdi, Robin Shattock, Nilay Shah |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
MDPI AG
2020-12-01
|
Saila: | Vaccines |
Gaiak: | |
Sarrera elektronikoa: | https://www.mdpi.com/2076-393X/9/1/3 |
Antzeko izenburuak
-
A self-amplifying RNA vaccine provides protection in a murine model of bubonic plague
nork: Robin John Shattock, et al.
Argitaratua: (2023-11-01) -
Vaccines’ New Era-RNA Vaccine
nork: Wenshuo Zhou, et al.
Argitaratua: (2023-08-01) -
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
nork: Bruna Aparecida Souza Machado, et al.
Argitaratua: (2021-11-01) -
Advancing mRNA technologies for therapies and vaccines: An African context
nork: Dylan Kairuz, et al.
Argitaratua: (2022-10-01) -
Immunogenicity of stabilized HIV-1 Env trimers delivered by self-amplifying mRNA
nork: Yoann Aldon, et al.
Argitaratua: (2021-09-01)